AEMD — Aethlon Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $3.83m
- -$4.15m
- $0.57m
- 26
- 34
- 39
- 24
Annual cashflow statement for Aethlon Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.22 | -6.38 | -7.89 | -10.4 | -12 |
| Depreciation | |||||
| Non-Cash Items | 1.46 | 1.27 | 0.777 | 0.781 | 1.22 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.436 | -0.115 | 0.31 | -0.251 | 0.065 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.29 | -5.2 | -6.76 | -9.77 | -10.5 |
| Capital Expenditures | 0 | -0.152 | -0.06 | -0.349 | -0.943 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.152 | -0.06 | -0.349 | -0.943 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.15 | 11.1 | 7.13 | 17.4 | 8.91 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.15 | 5.78 | 0.304 | 7.25 | -2.54 |